100 related articles for article (PubMed ID: 563594)
1. Derivatives of 3.3-spiro-bi-5-methyl-5'-alkylaminomethyl-tetrahydrofuranone-2 as potential neurotropic agents. II.
Wagner E; Bobrański B
Pol J Pharmacol Pharm; 1977; 29(5):565-9. PubMed ID: 563594
[TBL] [Abstract][Full Text] [Related]
2. Derivatives of 3, 3-spirobi-5-methyltetrahydrofuranone-2 as potential neurotropic agents. Part I.
Wagner E; Bobrański B
Pol J Pharmacol Pharm; 1976; 28(2):213-6. PubMed ID: 934950
[TBL] [Abstract][Full Text] [Related]
3. The central action of 1-p-dimethylaminophenyl-5-allyl-5-(beta-hydroxypropyl) barbituric acid and the corresponding lactone.
Hano J; Sypniewska M; Chojnacka-Wójcik E
Pol J Pharmacol Pharm; 1978; 30(1):55-61. PubMed ID: 565512
[TBL] [Abstract][Full Text] [Related]
4. Novel indolene-spiro-hydroxytetronimides as potential antineoplastic and antiviral agents.
Soliman FS; Salama HM
Pharmazie; 1983 Sep; 38(9):585-6. PubMed ID: 6647529
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and pharmacological properties of new derivatives of 1-diphenylacetamide-2-butanol.
Kolasa K; Kleinrok Z; Pietrasiewicz T; Czechowska G; Zejc A; Gajewczyk L
Pol J Pharmacol Pharm; 1989; 41(5):475-81. PubMed ID: 2577062
[TBL] [Abstract][Full Text] [Related]
6. Spirobutenolides substituted by arylpiperazinyl-carbonyl moieties. Synthesis and antinociceptive properties.
Bois F; Moreau S; Coudert P; Rubat C; Couquelet J
Arzneimittelforschung; 1998 Dec; 48(12):1156-62. PubMed ID: 9893930
[TBL] [Abstract][Full Text] [Related]
7. Synthesis of D,L beta-aminomethyl derivatives of gamma-(p-chlorophenyl)-tetrahydrofuran-2-one.
Jakóbiec T; Zabska R; Zawisza T
Pol J Pharmacol Pharm; 1982; 34(4):247-55. PubMed ID: 6820691
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and pharmacological properties of some 2-substituted 1-(3-pyridyl)-1,2,3,4-tetrahydro-beta-carbolines.
Misztal S; Boksa J; Chojnacka-Wójcik E; Tatarczyńska E; Lewandowska A
Pol J Pharmacol Pharm; 1987; 39(1):97-103. PubMed ID: 3499603
[TBL] [Abstract][Full Text] [Related]
9. Diazepinoquinazolines. Part II. Synthesis and pharmacological activity of some derivatives of 1,4-diazepino[2,1-b]quinazoline.
Guryn R; Szadowska A; Pakulska W
Acta Pol Pharm; 1994; 51(6):483-7. PubMed ID: 7762399
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and pharmacological properties of 2,4-disubstituted 5-amino-6-pyrimidinecarboxylic acid derivatives. Part III.
Jasztold-Howorko R; Machoń Z; Wilimowski M; Wojewódzki W; Barczyńska J; Kedzierska L; Orzechowska-Juzwenko K; Duś E; Dziewiszek W; Rutkowska M
Pol J Pharmacol; 1995; 47(5):435-40. PubMed ID: 8868136
[TBL] [Abstract][Full Text] [Related]
11. [New psychotropic agents. 2. Synthesis and pharmacologic activity of derivatives of 5H-pyrrolo[1,2-b][1,2,5]benzotriazepines].
Stefancich G; Artico M; Corelli F; Massa S; Pantaleoni GC; Palumbo G; Fanini D; Giorgi R
Farmaco Sci; 1985 Dec; 40(12):930-41. PubMed ID: 4092766
[TBL] [Abstract][Full Text] [Related]
12. Enhancement of pharmacological activity of CERM 3726 with a ground mixture of beta-cyclodextrin in mice.
Luu SN; Chaperon F; Leinot M; Pourrat A
Pharm Acta Helv; 1987; 62(12):335-6. PubMed ID: 3441478
[No Abstract] [Full Text] [Related]
13. [Molecular interaction between synthetic spirobutenolides and C1 esterase normal inhibitor].
Bador P; Ollier-Hartmann MP; Paris J; Hartmann L
C R Acad Sci III; 1986; 303(3):55-8. PubMed ID: 3093005
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and pharmacological activity of some 2,3-dihydrofuran-2,3-dione derivatives.
Zankowska-Jasińska W; Burgieł M; Golus J; Kolasa A; Walocha K; Zaleska B; Chojnacka-Wójcik E; Wiczyńska B; Tatarczyńska E
Pol J Pharmacol Pharm; 1982; 34(5-6):391-8. PubMed ID: 6985305
[TBL] [Abstract][Full Text] [Related]
15. Isolation, biological activity and synthesis of benzannulated spiroketal natural products.
Sperry J; Wilson ZE; Rathwell DC; Brimble MA
Nat Prod Rep; 2010 Aug; 27(8):1117-37. PubMed ID: 20648380
[No Abstract] [Full Text] [Related]
16. Studies on psychotropic agents. I. Synthesis of 3,8-disubstituted-1-oxa-3,8-diazaspiro[4,5]decan-2,4-dione derivatives.
Nagai Y; Maki A; Kanda H; Natsuka K; Umemoto S
Chem Pharm Bull (Tokyo); 1976 Jun; 24(6):1179-88. PubMed ID: 1021283
[No Abstract] [Full Text] [Related]
17. Structure-activity relationships of a series of novel (piperazinylbutyl)thiazolidinone antipsychotic agents related to 3-[4-[4-(6-fluorobenzo[b]thien-3-yl)-1-piperazinyl]butyl]-2,5,5- trimethyl-4-thiazolidinone maleate.
Hrib NJ; Jurcak JG; Bregna DE; Burgher KL; Hartman HB; Kafka S; Kerman LL; Kongsamut S; Roehr JE; Szewczak MR; Woods-Kettelberger AT; Corbett R
J Med Chem; 1996 Sep; 39(20):4044-57. PubMed ID: 8831770
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and properties of 4-substituted-1-piperazinyl-propyl derivatives of 1-phenyl-7-methylpyrimido-[4,5-d]pyrimidin-4-one.
Malinka W; Zajac HE; Dereń A; Zawisza T; Wilimowski M; Kedzierska-Goździk L; Barczyńska J; Rutkowska M; Wojewódzki W; Szelag A
Pol J Pharmacol Pharm; 1991; 43(5):369-79. PubMed ID: 1688093
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and central pharmacological screening of new aminoalkoxy derivatives of coumarin and chromene.
Suski S; Zawadowski T; Bogdal M; Przemyk B; Szafrański B
Pol J Pharmacol Pharm; 1992; 44(5):475-85. PubMed ID: 1297112
[TBL] [Abstract][Full Text] [Related]
20. Metabolic N-oxidation products of aliphatic amines as potential mediators in amine pharmacology.
Gorrod JW; Jenner P
Int J Clin Pharmacol Biopharm; 1975 Jul; 12(1-2):180-5. PubMed ID: 1172491
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
